(ISRG, AVL, BMJ, GORO, CRWE) Noticeable Stocks by CRWEFinance.com

FOR IMMEDIATE RELEASE
(Free-Press-Release.com) January 5, 2012 -- Intuitive Surgical, Inc. (Nasdaq:ISRG), headquartered in Sunnyvale, California, is the global technology leader in minimally invasive robotic-assisted surgery. Intuitive Surgical develops, manufactures and markets robotic technologies for a broad range of minimally invasive procedures, which help patients return quickly to active and productive lives.

Intuitive Surgical, Inc., the global leader in minimally invasive robotic-assisted surgery, yesterday announced that it received FDA clearance to market its EndoWrist(R) One(TM) Vessel Sealer instrument for use with the da Vinci(R) Si(TM) Surgical System.

The EndoWrist One Vessel Sealer is a wristed, single-use instrument intended for bipolar coagulation and mechanical transection of vessels up to 7 mm in diameter and tissue bundles that fit in the jaws of the instrument. The EndoWrist One Vessel Sealer enables da Vinci Si surgeons to fully control vessel sealing, while providing the benefits of da Vinci Surgery -- enhanced surgical precision, control and stability and 3D HD visualization.

Gary Guthart, CEO, Intuitive Surgical Inc., stated, "We are pleased to start 2012 with this clearance for our EndoWrist One Vessel Sealer. We plan to initiate a controlled rollout of this product in the US in the first quarter of 2012, while also submitting for CE Mark."

With the purchase of a dedicated radio frequency energy generator, the EndoWrist One Vessel Sealer is compatible with all da Vinci Si Surgical Systems. Customers seeking additional information should contact their local da Vinci Sales Representative.

For more information about Intuitive Surgical, please visit www.intuitivesurgical.com

Read the full article at: http://crwefinance.com/21707/stock-alerts/isrg-avl-bmj-goro-crwe-noticeable-stocks-by-crwefinancecom/

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

*****************************

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEFinance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEFinance.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://crwefinance.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.